Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma. (Q53407680)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

title

Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

main subject

head and neck squamous cell carcinoma

0 references

adaptive radiation therapy

0 references

author

Renato Talamini

series ordinal

5

object named as

Renato Talamini

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

author name string

Giovanni Franchin

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Emilio Minatel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Doriano Politi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Carlo Gobitti

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Emanuela Vaccher

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Maria Gabriella Savignano

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Marco Trovo

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Sandro Sulfaro

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

Luigi Barzan

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

language of work or name

English

0 references

publication date

1 June 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

published in

Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

volume

115

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

page(s)

2464-2471

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

cites work

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

21 January 2018

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

21 January 2018

Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

21 January 2018

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative radiotherapy in locally advanced head and neck cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCNCR.24252

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.24252

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

PubMed publication ID

19280588

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19280588

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19280588

ResearchGate publication ID

24195504

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53407680&oldid=2043825403"